NVS logo

Novartis AG (NVS) Net income

annual net income:

$11.94B-$2.91B(-19.59%)
December 31, 2024

Summary

  • As of today (August 3, 2025), NVS annual net profit is $11.94 billion, with the most recent change of -$2.91 billion (-19.59%) on December 31, 2024.
  • During the last 3 years, NVS annual net income has fallen by -$12.08 billion (-50.29%).
  • NVS annual net income is now -50.29% below its all-time high of $24.02 billion, reached on December 31, 2021.

Performance

1-year change

-19.59%

3-year change

-50.29%

5-year change

+1.78%

15-year change

+55.02%

NVS Net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

99.59%
NVS annual net profit is higher than 99.59% of companies in Healthcare sector

Range

All-time high

$24.02B
NVS annual net profit is currently -50.29% below its historical high of $24.02 billion

3-year low

$6.96B
NVS annual net profit is currently +71.69% above its 3-year low

Earnings dates

Last annual earnings report date

Dec 31, 2024
NVS previous annual earnings announcement was published on Dec 31, 2024

Next annual earnings report date

N/A
NVS next annual earnings announcement has not yet been scheduled

OtherNVSincome statement metrics

annual net margin

23.09%
NVS annual net profit margin is 23.09%

Annual revenue

$51.72B
NVS annual revenue is $51.72 billion

Annual gross profit

$38.90B
NVS annual gross profit is $38.90 billion

Annual EPS

$5.87
NVS annual earnings per share is $5.87

quarterly net income:

$4.04B+$435.00M(+12.06%)
June 30, 2025

Summary

  • As of today (August 3, 2025), NVS quarterly net profit is $4.04 billion, with the most recent change of +$435.00 million (+12.06%) on June 30, 2025.
  • Over the past year, NVS quarterly net income has increased by +$795.00 million (+24.49%).
  • NVS quarterly net income is now -75.22% below its all-time high of $16.31 billion, reached on December 31, 2021.

Performance

3-month change

+12.06%

1-year change

+24.49%

3-year change

+138.55%

5-year change

+116.44%

NVS quarterly net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

99.74%
NVS quarterly net profit is higher than 99.74% of companies in Healthcare sector

Range

All-time high

$16.31B
NVS quarterly net profit is currently -75.22% below its historical high of $16.31 billion

3-year low

$1.47B
NVS quarterly net profit is currently +175.65% above its 3-year low

Earnings dates

Last quarterly earnings report date

Jun 30, 2025
NVS previous earnings announcement was published on Jun 30, 2025

Next quarterly earnings report date

Oct 28, 2025
NVS next earnings announcement is scheduled for Oct 28, 2025

OtherNVSincome statement metrics

Quarterly net margin

27.24%
NVS quarterly net profit margin is 27.24%

Quarterly revenue

$14.84B
NVS quarterly revenue is $14.84 billion

quarterly gross profit

$11.51B
NVS quarterly gross profit is $11.51 billion

Quarterly EPS

$2.06
NVS quarterly earnings per share is $2.06

TTM net income:

$13.65B+$795.00M(+6.18%)
June 30, 2025

Summary

  • As of today (August 3, 2025), NVS TTM net profit is $13.65 billion, with the most recent change of +$795.00 million (+6.18%) on June 30, 2025.
  • Over the past year, NVS TTM net income has dropped by -$2.52 billion (-15.59%).
  • NVS TTM net income is now -43.54% below its all-time high of $24.18 billion, reached on March 31, 2022.

Performance

3-month change

+6.18%

1-year change

-15.59%

3-year change

-40.59%

5-year change

+89.38%

NVS TTM net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

99.57%
NVS TTM net profit is higher than 99.57% of companies in Healthcare sector

Range

All-time high

$24.18B
NVS TTM net profit is currently -43.54% below its historical high of $24.18 billion

3-year low

$6.96B
NVS TTM net profit is currently +96.32% above its 3-year low

Earnings dates

Last quarterly earnings report date

Jun 30, 2025
NVS previous earnings announcement was published on Jun 30, 2025

Next quarterly earnings report date

Oct 28, 2025
NVS next earnings announcement is scheduled for Oct 28, 2025

OtherNVSincome statement metrics

annual net margin

23.09%
NVS annual net profit margin is 23.09%

TTM revenue

$55.19B
NVS TTM revenue is $55.19 billion

TTM gross profit

$42.08B
NVS TTM gross profit is $42.08 billion

TTM EPS

$6.86
NVS TTM earnings per share is $6.86

Net income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

annual net income

$11.94B
NVS annual net profit is $11.94 billion

Annual revenue

$51.72B
NVS annual revenue is $51.72 billion

annual cost of goods sold

$12.83B
NVS annual cost of goods sold is $12.83 billion

annual operating expenses

$24.35B
NVS annual total operating expenses is $24.35 billion

annual interest expense

$1.01B
NVS annual interest expense is $1.01 billion

annual income tax

$1.70B
NVS annual income tax is $1.70 billion

NVS Net income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-19.6%+24.5%-15.6%
3 y3 years-50.3%+138.6%-40.6%
5 y5 years+1.8%+116.4%+89.4%

NVS Net income Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-50.3%+71.7%-52.4%+175.7%-40.6%+96.3%
5 y5-year-50.3%+71.7%-75.2%+175.7%-43.5%+96.3%
alltimeall time-50.3%+211.3%-75.2%+542.5%-43.5%+985.4%

NVS Net income History

DateAnnualQuarterlyTTM
Jun 2025
-
$4.04B(+12.1%)
$13.65B(+6.2%)
Mar 2025
-
$3.61B(+28.0%)
$12.86B(+7.7%)
Dec 2024
$11.94B(-19.6%)
$2.82B(-11.6%)
$11.94B(-32.2%)
Sep 2024
-
$3.19B(-1.8%)
$17.60B(+8.8%)
Jun 2024
-
$3.25B(+20.8%)
$16.18B(+6.1%)
Mar 2024
-
$2.69B(-68.3%)
$15.24B(+2.7%)
Dec 2023
$14.85B(+113.5%)
$8.48B(+381.5%)
$14.85B(+89.5%)
Sep 2023
-
$1.76B(-24.0%)
$7.84B(+2.5%)
Jun 2023
-
$2.32B(+1.0%)
$7.65B(+8.9%)
Mar 2023
-
$2.29B(+56.4%)
$7.03B(+1.0%)
Dec 2022
$6.96B(-71.0%)
$1.47B(-6.8%)
$6.96B(-68.1%)
Sep 2022
-
$1.57B(-7.1%)
$21.80B(-5.2%)
Jun 2022
-
$1.69B(-23.8%)
$22.98B(-5.0%)
Mar 2022
-
$2.22B(-86.4%)
$24.18B(+0.7%)
Dec 2021
$24.02B(+197.6%)
$16.31B(+491.3%)
$24.02B(+144.9%)
Sep 2021
-
$2.76B(-4.8%)
$9.81B(+9.2%)
Jun 2021
-
$2.90B(+40.7%)
$8.98B(+12.9%)
Mar 2021
-
$2.06B(-1.7%)
$7.96B(-1.4%)
Dec 2020
$8.07B(-31.2%)
$2.09B(+8.2%)
$8.07B(+13.6%)
Sep 2020
-
$1.94B(+3.6%)
$7.10B(-1.5%)
Jun 2020
-
$1.87B(-14.2%)
$7.21B(-40.6%)
Mar 2020
-
$2.18B(+93.4%)
$12.14B(+3.5%)
Dec 2019
$11.73B(-7.0%)
$1.13B(-44.9%)
$11.73B(-0.6%)
Sep 2019
-
$2.04B(-70.0%)
$11.80B(+3.7%)
Jun 2019
-
$6.80B(+285.0%)
$11.38B(-7.8%)
Mar 2019
-
$1.77B(+47.8%)
$12.35B(-2.1%)
Dec 2018
$12.61B(+63.7%)
$1.20B(-26.4%)
$12.61B(-5.8%)
Sep 2018
-
$1.62B(-79.1%)
$13.39B(-3.3%)
Jun 2018
-
$7.77B(+283.6%)
$13.85B(+71.8%)
Mar 2018
-
$2.02B(+2.5%)
$8.06B(+4.7%)
Dec 2017
$7.70B(+14.8%)
$1.98B(-5.0%)
$7.70B(+15.2%)
Sep 2017
-
$2.08B(+5.1%)
$6.68B(+2.2%)
Jun 2017
-
$1.98B(+18.8%)
$6.54B(+2.8%)
Mar 2017
-
$1.67B(+74.1%)
$6.37B(-5.1%)
Dec 2016
$6.71B(-62.3%)
$957.00M(-50.7%)
$6.71B(-1.4%)
Sep 2016
-
$1.94B(+7.5%)
$6.81B(+0.8%)
Jun 2016
-
$1.80B(-10.3%)
$6.76B(-0.5%)
Mar 2016
-
$2.01B(+90.8%)
$6.79B(-61.8%)
Dec 2015
$17.78B(+74.2%)
$1.05B(-44.2%)
$17.78B(-2.4%)
Sep 2015
-
$1.89B(+2.8%)
$18.22B(-6.8%)
Jun 2015
-
$1.84B(-85.9%)
$19.55B(-3.5%)
Mar 2015
-
$13.01B(+772.2%)
$20.27B(+98.6%)
Dec 2014
$10.21B(+11.3%)
$1.49B(-53.7%)
$10.21B(-5.0%)
Sep 2014
-
$3.22B(+26.1%)
$10.75B(+10.2%)
Jun 2014
-
$2.56B(-13.1%)
$9.76B(+0.4%)
Mar 2014
-
$2.94B(+44.9%)
$9.72B(+5.9%)
Dec 2013
$9.18B(-1.0%)
$2.03B(-9.1%)
$9.18B(+0.5%)
Sep 2013
-
$2.23B(-11.3%)
$9.13B(-1.7%)
Jun 2013
-
$2.52B(+4.9%)
$9.29B(-1.4%)
Mar 2013
-
$2.40B(+20.8%)
$9.42B(+1.6%)
Dec 2012
$9.27B
$1.99B(-16.9%)
$9.27B(+11.9%)
Sep 2012
-
$2.39B(-9.7%)
$8.29B(-0.9%)
DateAnnualQuarterlyTTM
Jun 2012
-
$2.65B(+17.8%)
$8.36B(-0.7%)
Mar 2012
-
$2.25B(+124.3%)
$8.42B(-5.9%)
Dec 2011
$8.94B(-8.7%)
$1.00B(-59.3%)
$8.94B(-11.5%)
Sep 2011
-
$2.46B(-8.9%)
$10.11B(+1.9%)
Jun 2011
-
$2.70B(-2.4%)
$9.92B(+3.0%)
Mar 2011
-
$2.77B(+27.7%)
$9.63B(-1.7%)
Dec 2010
$9.79B(+16.6%)
$2.17B(-4.7%)
$9.79B(-1.4%)
Sep 2010
-
$2.27B(-5.9%)
$9.93B(+1.8%)
Jun 2010
-
$2.42B(-17.6%)
$9.75B(+4.1%)
Mar 2010
-
$2.93B(+27.2%)
$9.37B(+11.6%)
Dec 2009
$8.40B(+2.5%)
$2.31B(+9.9%)
$8.40B(+10.0%)
Sep 2009
-
$2.10B(+3.1%)
$7.63B(+0.1%)
Jun 2009
-
$2.04B(+3.7%)
$7.63B(-2.7%)
Mar 2009
-
$1.96B(+27.5%)
$7.84B(-4.3%)
Dec 2008
$8.20B(-31.4%)
$1.54B(-26.4%)
$8.20B(+8.4%)
Sep 2008
-
$2.09B(-7.1%)
$7.56B(-38.7%)
Jun 2008
-
$2.25B(-2.9%)
$12.34B(+2.0%)
Mar 2008
-
$2.32B(+156.3%)
$12.09B(+1.2%)
Dec 2007
$11.95B(+66.5%)
$904.00M(-86.8%)
$11.95B(-5.9%)
Sep 2007
-
$6.87B(+241.9%)
$12.70B(+64.9%)
Jun 2007
-
$2.01B(-7.4%)
$7.70B(+4.1%)
Mar 2007
-
$2.17B(+31.1%)
$7.40B(+3.1%)
Dec 2006
$7.17B(+17.0%)
$1.65B(-11.4%)
$7.17B(+4.4%)
Sep 2006
-
$1.87B(+9.4%)
$6.87B(+3.1%)
Jun 2006
-
$1.71B(-12.3%)
$6.66B(+0.9%)
Mar 2006
-
$1.95B(+44.2%)
$6.60B(+7.6%)
Dec 2005
$6.13B(+14.3%)
$1.35B(-18.6%)
$6.14B(+6.5%)
Sep 2005
-
$1.66B(+0.8%)
$5.76B(+2.0%)
Jun 2005
-
$1.65B(+11.1%)
$5.65B(+1.7%)
Mar 2005
-
$1.48B(+51.7%)
$5.55B(+3.5%)
Dec 2004
$5.37B(+13.1%)
$976.00M(-36.9%)
$5.37B(-2.0%)
Sep 2004
-
$1.55B(-0.1%)
$5.48B(+5.2%)
Jun 2004
-
$1.55B(+19.8%)
$5.21B(+4.7%)
Mar 2004
-
$1.29B(+19.0%)
$4.97B(+4.8%)
Dec 2003
$4.74B(+0.4%)
$1.09B(-14.9%)
$4.74B(-1.9%)
Sep 2003
-
$1.28B(-3.0%)
$4.83B(+3.6%)
Jun 2003
-
$1.32B(+23.8%)
$4.67B(-1.6%)
Mar 2003
-
$1.06B(-9.8%)
$4.75B(-0.6%)
Dec 2002
$4.72B(+23.2%)
$1.18B(+6.1%)
$4.77B(+13.0%)
Sep 2002
-
$1.11B(-20.2%)
$4.22B(-0.4%)
Jun 2002
-
$1.39B(+27.7%)
$4.24B(+9.1%)
Mar 2002
-
$1.09B(+73.3%)
$3.89B(+0.5%)
Dec 2001
$3.84B(-14.1%)
$629.00M(-44.2%)
$3.87B(-12.2%)
Sep 2001
-
$1.13B(+8.6%)
$4.40B(+6.1%)
Jun 2001
-
$1.04B(-3.0%)
$4.15B(-5.5%)
Mar 2001
-
$1.07B(-8.0%)
$4.39B(-4.1%)
Dec 2000
$4.47B(+6.8%)
$1.16B(+32.9%)
$4.58B(+34.1%)
Sep 2000
-
$876.00M(-31.7%)
$3.42B(+34.5%)
Jun 2000
-
$1.28B(+1.9%)
$2.54B(+101.9%)
Mar 2000
-
$1.26B
$1.26B
Dec 1999
$4.18B(-4.3%)
-
-
Dec 1998
$4.37B
-
-

FAQ

  • What is Novartis AG annual net profit?
  • What is the all time high annual net income for Novartis AG?
  • What is Novartis AG annual net income year-on-year change?
  • What is Novartis AG quarterly net profit?
  • What is the all time high quarterly net income for Novartis AG?
  • What is Novartis AG quarterly net income year-on-year change?
  • What is Novartis AG TTM net profit?
  • What is the all time high TTM net income for Novartis AG?
  • What is Novartis AG TTM net income year-on-year change?

What is Novartis AG annual net profit?

The current annual net income of NVS is $11.94B

What is the all time high annual net income for Novartis AG?

Novartis AG all-time high annual net profit is $24.02B

What is Novartis AG annual net income year-on-year change?

Over the past year, NVS annual net profit has changed by -$2.91B (-19.59%)

What is Novartis AG quarterly net profit?

The current quarterly net income of NVS is $4.04B

What is the all time high quarterly net income for Novartis AG?

Novartis AG all-time high quarterly net profit is $16.31B

What is Novartis AG quarterly net income year-on-year change?

Over the past year, NVS quarterly net profit has changed by +$795.00M (+24.49%)

What is Novartis AG TTM net profit?

The current TTM net income of NVS is $13.65B

What is the all time high TTM net income for Novartis AG?

Novartis AG all-time high TTM net profit is $24.18B

What is Novartis AG TTM net income year-on-year change?

Over the past year, NVS TTM net profit has changed by -$2.52B (-15.59%)
On this page